Abstract
Introduction
Percutaneous endoscopic cecostomy (PEC) is a viable treatment option for patients with persistent or recurrent acute colonic pseudo-obstruction (ACPO; Ogilvie’s syndrome). It should be generally considered in patients that are refractory to pharmacologic and endoscopic decompression, especially those not amenable to surgical intervention due to an increased perioperative risk. Physicians are rather unfamiliar with this approach given the limited number of reports in the literature and paucity of guideline resources, although guidelines concerning ACPO and covering the role of endoscopy were recently published by three major expert societies, all within the last 2 years.
Patients and methods
We retrospectively identified three consecutive patients who underwent PEC placement at a Czech tertiary referral center between May 2018 and December 2021: all for recurrent ACPO. In addition, we summarized the current guidelines in order to present the latest knowledge related both to the procedure and management approach in patients with ACPO.
Results
The placement of PEC was successful and resulted in clinical improvement in all cases without any adverse events.
Conclusion
The results of our experience are in line with previous reports and suggest that PEC may become a very useful tool in the armamentarium of modalities utilized to treat ACPO. Furthermore, the availability of guideline resources now offers comprehensive guidance for informed decision-making and the procedural aspects.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Acute colonic pseudo-obstruction (ACPO), more commonly known as Ogilvie’s syndrome, refers to pathologic dilatation of the colon without underlying mechanical obstruction [1]. It occurs primarily in elderly, hospitalized, or institutionalized patients with comorbid conditions, infection, metabolic imbalance, or who are recovering from surgery or trauma (Table 1) [2,3,4]. The precise pathogenesis is unknown, but evidence suggests an alteration in the autonomic nervous system resulting in colonic atony [5, 6]. A United States-based retrospective cohort study estimated the incidence of ACPO to approximately 100 cases of 100,000 hospital admissions per year [7]. The main clinical features include acute massive abdominal distention and pain along with nausea, vomiting, and altered bowel function [8,9,10]. The diagnosis is established by abdominal imaging using computed tomography (CT) or water-soluble contrast enema, showing colonic dilatation without evidence of mechanical obstruction [11, 12].
The goal of management is to decompress the distended colon to minimize the risk of mural ischemia and colonic perforation, both associated with high mortality [2]. Supportive measures remain the first-line step and include identification and discontinuation of precipitating factors (e.g., medication), correcting fluid and electrolyte disturbances, maintaining patients with nil per os, decompressing the GI tract by nasogastric or rectal tubes, and frequent position changes [10,11,12]. In case the condition is not improving with supportive care, both medical therapy with neostigmine and decompressive colonoscopy are considered valid options [12,13,14].
In patients with ACPO in whom supportive, pharmacologic, and conventional endoscopic therapies fail, percutaneous endoscopic cecostomy/colostomy (PEC) may be considered before proceeding with surgical interventions [15, 16]. The method was first described by Ponsky and colleagues (1986) as an alternative to surgically or radiographically placed colostomy in two patients who were unsuccessfully treated with decompressive colonoscopy [17]. Since then, it has been gradually extending into practice, although its widespread use has been limited. Successful utilization of PEC requires local familiarity with the method, cautious indication, available expertise, and multidisciplinary support. However, our experience indicates that treating physicians and/or endoscopists are generally not acquainted with the procedure, perhaps because of its rarity due to the few defined indications, infrequent occurrence in the literature, and a relative paucity of guideline resources given the fact that major endoscopic and surgical societies published applicable recommendations just recently.
We report a case series of patients with ACPO who were ultimately managed with PEC placement after traditional therapeutic approaches had failed. In addition, we describe our experience in the context of the literature and the newly published recommendations, providing guidance on the therapeutic approach in ACPO along with indications, techniques, and periprocedural management.
Patients and methods
We identified three consecutive patients who underwent PEC placement at a Czech tertiary referral center: all for recurrent ACPO. The procedures were performed between May 2018 and December 2021 and are presented in chronological order as a single-center retrospective case series, reported in line with the PROCESS 2020 Guideline [18]. The interventions were performed using a modification of the technique initially described by Ponsky and colleagues, which was originally derived from the pull-through variant of percutaneous endoscopic gastrostomy (PEG) [17]. Given that all patients presented with ACPO, no oral bowel preparation was attempted, but the patients were kept fasted for at least 12 h prior to the procedure. Intravenous antibiotics (amoxicillin/clavulanic acid) were administered prophylactically before the procedure to provide coverage against both gram-negative (fecal) and gram-positive (skin) bacteria, and they were continued for 24 h post-intervention.
The procedures were conducted with the patient lying supine and under general anesthesia in case 1, whereas cases 2 and 3 involved conscious sedation utilizing titrated doses of midazolam, with the active participation of two operators. All three cases were managed by a consistent team of two skilled advanced endoscopists. Refer to Video 1 (Online Supplementary Material), which offers a detailed demonstration of all procedural aspects from both endoscopic and external viewpoints. First, a standard adult colonoscope was advanced into the right colon with transillumination of the abdominal wall to identify a suitable puncture site (Fig. 1). Notably, appropriate attention was devoted to keep CO2 insufflation at minimum to avoid the risk of perforation of the already distended colon. Following intubation of the cecum, the adjacent lumen was cleansed to remove fecal material. The proper position was confirmed by an indentation of the cecum with direct digital pressure on the abdominal wall. The abdominal wall was then prepared with betadine solution, anesthetized (1% trimecaine), and draped in a sterile fashion. The contents of a standard, commercially available PEG kits with 24F tubes and an anchor suture system (PEG-24-PULL-I-S and Cope Gastrointestinal Suture Anchor Set, Cook, Inc., Bloomington, IN, USA) were subsequently used. Provided that sufficient transillumination was achieved, a dedicated kit needle preloaded with the anchor system was introduced through the abdominal wall into the cecum. An intracolic position was confirmed by direct visualization and aspiration of air into a syringe. A stylet wire was then passed through the needle, advancing a T-anchor into the colon. The wire and needle were then removed, and the colon apposed anteriorly to the abdominal wall by gentle traction on the anchor suture. The cecum was gradually fixated using a total of three T-anchors in a triangular configuration approximately 3 cm apart (Fig. 2). The center of the cecopexy site was then punctured with a 19-gauge Seldinger needle. A traction wire was passed through the needle, grasped by a snare, and then withdrawn from the colon along with the colonoscope. The remainder of the procedure was analogical as for the insertion of PEG using the pull technique, with the tube slowly trailed through the anus, colon, and abdominal wall. The correct position was confirmed by reinsertion of the colonoscope (Fig. 3). Simultaneously, the wound site was covered with sterile dressing, and the tube was fastened by an external bumper. The T-anchors were removed 1–2 weeks later.
From the therapeutic point of view, the PEC tube was left open for the first 24 h to allow venting. After that, the tube was capped and regularly flushed with 30–60 mL of tap water every 8 h to keep it patent. In addition, it was opened 2–4 times daily for decompression based on the course of the condition in each patient.
Case series
The patient and procedure characteristics including outcomes are summarized in Table 2. Notably, case 1 was also reported as the first procedure of its kind in the Czech Republic [19].
Case 1
An 89-year-old immobile female with an extensive past medical history including two ischemic strokes, multiple fractures due to falls at home, and dementia was referred for severe abdominal pain, vomiting, and dehydration. The initial abdominal radiograph showed marked dilatation of the colon with multiple air-fluid levels (Fig. 4), while laboratory analysis did not reveal any significant or pathognomonic findings. Abdominal CT was performed, excluding mechanical obstruction or other organic pathology (Fig. 5). The patient was diagnosed with ACPO and admitted for conservative treatment. Nevertheless, comprehensive care including maximum pharmacotherapy with neostigmine did not bring sufficient clinical effect. Decompressive colonoscopy was necessary, although ACPO recurred within a few days necessitating repeated colonoscopies. Given that conventional therapy had failed, surgical colostomy with possible subtotal colectomy as the utmost option was proposed, but the idea was abandoned because of poor surgical candidacy. Finally, PEC was performed without any adverse events and with immediate effect, prompting patient discharge to a nursing home a week later. The cecostomy functioned well and had been used intermittently as a decompression and irrigation canal for the next 15 months, at which time the patient succumbed to natural causes.
Case 2
A 67-year-old male with generalized salivary gland carcinoma and multiple comorbid conditions developed severe obstipation with abdominal distension, necessitating protracted use of enemas and laxatives. The condition gradually progressed to the point when the patient required hospitalization and colonoscopic decompression, which had only a temporary effect lasting 48 h. It was established as a paraneoplastic case of ACPO, and the patient was indicated for PEC by a multidisciplinary team decision. After the procedure the symptoms of intestinal obstruction improved and bowel movements were restored, however the patient succumbed to his malignancy within 2 months. Of note, the patient had the colostomy tube placed in the proximal part of the ascending colon given that pseudomembranes and underlying trophic changes of the cecal mucosa were noted during the procedure. Moreover, his cecum was localized in an atypical position and transilluminated above the umbilicus.
Case 3
A 66-year-old obese male with a body mass index of 35 was initially admitted due to acute epididymitis. The hospital stay was complicated by gentamicin-associated acute renal injury, which confined the patient to bed for extended time and resulted in ACPO. Conservative management was not successful, and the patient was referred to our department for endoscopic decompression. Two decompressive colonoscopies were performed but resolved symptoms only for 2 and 3 days, respectively. Being a poor operative candidate, the patient required PEC placement. Cecostomy provided immediate decompression and led to durable symptom relief without any adverse events, after which the patient was discharged. The tube was sealed 8 weeks after placement in the absence of further need for decompression, given that the patient had restored mobility and regular defecation. The tube was removed 3 months after placement by cutting it at the skin level and pushing it into the colon under endoscopic visualization, after which it was extracted using a snare. The fistula tract healed uneventfully within 2–3 weeks, and the patient was without any symptoms of colonic distention at 12 months.
Current guidelines
Guidelines concerning ACPO and covering the role of endoscopy were recently published by the European Society of Gastrointestinal Endoscopy (ESGE), the American Society for Gastrointestinal Endoscopy (ASGE), and the American Society of Colon and Rectal Surgeons (ASCRS), all within the last 2 years [12,13,14]. Figure 6 outlines the recommended treatment algorithm.
Baseline laboratory analysis, including complete blood count, metabolic panel, and thyroid hormones, should be performed during the initial evaluation to look for predisposing and treatable causes [12, 14]. Supportive care remains the first-line therapy in patients with uncomplicated course, i.e., absence of ischemia or peritonitis and cecal diameter < 12 cm. It comprises maintaining the patient with nil per os, fluid resuscitation, correcting electrolytes, nasogastric or rectal tube insertion, ambulation, treatment of underlying disease, and avoidance of culprit medication [12,13,14]. The pharmacologic agent of choice is neostigmine, a short-acting cholinesterase inhibitor, and it is indicated in patients in whom symptoms persist beyond 48–72 h despite supportive care [12,13,14]. Contraindications to its use include evidence of intestinal or urinary obstruction and cardiopulmonary monitoring with immediate access to atropine in the event of bradycardia is recommended [13, 14]. Neostigmine is typically administered intravenously in a single bolus of 2–5 mg, with a second dose reserved for initial non-responders or partial responders. However, a consensus on dosing does not exist and routes of administration vary [4, 13, 14].
Nonoperative methods of colonic decompression are generally recommended in patients who have failed supportive measures, are not candidates for conservative management, or in whom neostigmine is contraindicated or ineffective [12,13,14]. Notably, as there are no prospective head-to-head trials between decompressive colonoscopy and neostigmine therapy, no recommendation can be made for the superiority of one of these options; the choice of treatment strategy should also depend on local expertise and situation, e.g., access to urgent colonoscopy [12]. Nonetheless, prompt endoscopic decompression by means of colonoscopic desufflation is recommended in cecal diameter > 12 cm or if the syndrome exists longer than 4–6 days [12]. The risk of ACPO recurrence after successful decompression varies widely in the literature, ranging from 0 to 50% [20, 21], and repeated endoscopic decompressions with colonic tube placement as an alternative may be considered in these cases [12].
Patients that are refractory to pharmacologic and endoscopic decompression, especially those not amenable to surgical intervention due to an increased perioperative risk, should be considered for PEC [12, 14]. The necessary steps include good bowel cleansing, use of sedation, disinfection of the abdominal wall, transillumination, and fixation of the colon to the abdominal wall [12]. As mortality rates are substantial in ACPO patients requiring surgical interventions, all efforts should be made to manage this patient population nonoperatively [13]. Surgery is the most appropriate step in cases complicated by peritonitis, colonic ischemia, and/or perforation or when all other options fail, and it includes surgically placed cecostomy tube, colostomy, or subtotal colectomy [13, 14].
Discussion
Management of patients with ACPO is challenging, with the goal of maximal mitigation of symptoms and prevention of potential adverse events associated with the condition. The effectiveness of pharmacologic and endoscopic therapy has reduced the need for surgery to cases complicated by colonic ischemia, perforation, or colonic dilatation otherwise refractory to nonoperative options [4, 8, 10, 20, 22]. The method of PEC serves as an important alternative especially in patients that are unfit for surgery [12, 23]. The procedure has evolved from the method of PEG and was first described in 1986 [17]. Nonetheless, its widespread use has been limited with scarce literature regarding technique, efficacy and safety, seldom indications, and a lack of awareness among physicians.
In general, studies on PEC are sparse and data collection is retrospective. Based on a recent systematic review by Khayyat on therapeutic utility of PEC in adults, the existing evidence is heterogeneous and consists mainly of case reports and case series [24]. Up until 2020 the dedicated guideline resource on PEC placement had been the recommendations by the National Institute for Health and Clinical Excellence published in 2006 [25]. However, according to the evidence used to support this guidance, the literature review was limited to one case series and three case reports. Several more studies reported data regarding PEC in various indications since then, however, the total number of patients with ACPO remains relatively low. Baraza and colleagues performed 35 PECs in 33 patients, of whom 4 had recurrent ACPO and were considered poor surgical candidates [26]. Symptoms resolved in 26 patients (74%), including 3 of the 4 with ACPO. Major adverse events occurred in 4 patients (3 had peritonitis secondary to fecal contamination; 1 patient died). Another study by Lynch and colleagues reported data on PEC placement in 8 patients: 6 for ACPO and 2 for chronic constipation [16]. Seven of the 8 cases were successful and resulted in clinical improvement, 1 patient required surgical removal of the PEC tube for fecal spillage resulting in peritonitis. Cowlam and colleagues reported their experience with an improvement in symptoms in 81% of 31 patients treated with PEC, including 5 patients with ACPO [27]. Nonetheless, 3 of these 5 patients had to have the tube removed because of infection and 1 patient died from fecal peritonitis. Similar outcomes were reported by other authors [15, 17, 28].
Conveniently regarding the aforementioned, dedicated guidelines covering the role of PEC in the management of ACPO were recently published by three major societies. The aim within the ESGE guideline was for the first time to provide guidance on the technique and management of PEC placement in patients with intractable constipation and ACPO [12]. The ASGE document updated on the role of endoscopy in the management of colonic volvulus and ACPO [13]. The ASCRS guideline focused on the evaluation and treatment of sigmoid or cecal volvulus and ACPO [14].
Indications for the procedure include intermittent or continuous decompression in refractory ACPO, colon fixation in recurrent colonic volvulus, and antegrade colonic enema in selected cases of evacuatory disorder or constipation not responding to other options [12,13,14, 25]. Oral bowel preparation should not be used in ACPO as it may worsen colonic dilatation in the absence of bowel transit [12, 22]; however, it is recommended in cases of intractable constipation as abundant fecal remnants might increase the risk of septic adverse events [12]. Even though there has been no study addressing the need for antibiotics, they have been administered in general practice in view of the potential fecal contamination [15, 16, 29,30,31,32]. According to the ESGE guideline, antibiotic prophylaxis should follow local protocols and start 1 h prior and continue for 3 days post-procedure [12]; the other guidelines did not report on this [13, 14, 25]. In addition, the procedure should be performed with CO2 insufflation and the patient in the left lateral or supine position.
The cecum is the preferred location of PEC placement unless it is technically not feasible [12, 13]. While it is possible to perform colostomy at other locations, there are no data demonstrating any advantages [26, 27, 33, 34]. Furthermore, cecal transillumination is a prerequisite to increase safety and procedure ease as it helps in determining the most direct route into the colon. Cecostomy also allows pancolonic rather than distal enema in order to provide more effective bowel function [35]. Notwithstanding, sigmoid volvulus is a specific situation in which reported techniques vary in terms of the number and site of fixation [13, 14]. Some authors suggest inserting colostomy in two locations, preferably on both limbs of the volvulus to fix the colon and prevent further “twisting” [23].
Three main techniques have been used in clinical practice: the pull-through method, the introducer (“push”) method, and laparoscopically assisted PEC (LAPEC) [16, 26, 29, 32, 36, 37]. The existing data do not provide evidence as to which method should be preferred, and the method itself has not been standardized [12,13,14]. Surprising differences exist regarding the type and size of tubes, which is likely to play a role in the efficacy and tolerability of the system [24]. Nonetheless, ESGE recommends fixing the colon to the abdominal wall at three points using T-anchors, a double-needle suturing device, or laparoscopic fixation, whatever method is used [12]. This is key in ensuring a stable colon position during the procedure to prevent leaks. The technical success rates of solely endoscopic cecostomy surpass 80%; adverse events occur in 30–40%, and quality of life improves for most patients, even though acceptance is reduced in approximately 25% of patients, mostly because of pain [12, 15, 16, 27, 29, 30, 38,39,40,41,42,43]. Although most adverse events are minor, mortality has been noted secondary to endoscopic colostomy-induced fecal peritonitis [24, 25, 35, 38]. LAPEC showed a technical success rate of 95%, which exceeds the rates reported for endoscopic cecostomy [36]. In critically ill and fragile patients, however, the endoscopic route might be preferred to avoid surgery and extensive sedation [12].
PEC offers several advantages over surgery. Most importantly, general anesthesia can be avoided. Furthermore, the presence of a cecostomy tube prevents stoma stenosis, and the tube is reversible without a need for second operation, although a procedure is still required. Once in place, the PEC tube may be left open for venting. An antegrade enema with polyethylene glycol solution can also be given after initial resolution of ACPO to decrease the risk of recurrence [12, 13, 44]. The tube may be removed once bowel movements are restored and underlying disease leading to ACPO has been treated [12]. Contraindications to the procedure are mechanical obstruction, failure of transillumination, presence of intestinal ischemia, abdominal wall infection, ascites, uncorrected coagulopathy, and sepsis [23, 45].
In our experience limited to three patients, the understanding of the procedure and handling of the PEC system was very intuitive. The learning curve was short, and it rendered the procedures smooth and deliberate, without any adverse events recorded. The placement of PEC was successful and resulted in clinical improvement in all cases (Table 2). One patient (case 2) had to have the colostomy tube placed proximally in the ascending colon because pathologic findings in the cecum made it unfeasible for placement. This was attributed to trophic changes of the cecal mucosa, knowing that some degree of right-sided colon ischemia may be present in approximately 10% of ACPO patients at the time of colonoscopy [13]. Tube removal and fistula closure were uneventful in the single patient in our series (case 3). The tube was removed with colonoscopy assistance. There have been reports of PEC removal by direct traction, although this should be avoided because it could result in cecal tearing or cecostomy tract disruption [15, 16].
The limitations of our study are the small number of patients and its retrospective nature. Yet it reflects the rarity of PEC performance in current practice, and it represents the only series describing the use of PEC in our country to date. Furthermore, our study contributes valuable data to the entire cohort of patients undergoing such a procedure, potentially enhancing the robustness of reporting in the field. Importantly, our manuscript is also accompanied by an illustrative video showcasing the refined PEC technique that had been successfully used in all our patients, providing a recent perspective on PEC placement adhering to the newly published recommendations. For instance, it demonstrates the fixation of the colon to the abdominal wall using 3 T-anchors, a practice that might have been overlooked in earlier studies but is now considered a recommended approach [12]. All preceding series were conducted prior to the availability of dedicated guidelines.
Conclusion
While most patients with ACPO are managed successfully with conventional measures, a subset remains therapeutically challenging. This shows the importance of raising awareness of the entire scope of management options, especially with the increasing numbers of frail octogenarians and nonagenarians. The availability of guideline resources now offers comprehensive guidance for informed decision-making and the procedural aspects.
The results of our experience are in line with previous reports and suggest that PEC may become a very useful tool in the armamentarium of modalities utilized to treat ACPO. Albeit certainly not devoid of adverse events, it offers an alternative for selected patients who would otherwise linger through repeated hospitalizations, multiple decompressive colonoscopies, and for whom surgery represents a disproportionate risk. Nonetheless, large and prospective trials are required in order to truly quantify advantages, if any, over existing treatment strategies, especially in terms of efficacy and safety.
References
Ogilvie H (1948) Large-intestine colic due to sympathetic deprivation; a new clinical syndrome. Br Med J 2(4579):671–673. https://doi.org/10.1136/bmj.2.4579.671
Vanek VW, Al-Salti M (1986) Acute pseudo-obstruction of the colon (Ogilvie’s syndrome). An analysis of 400 cases. Dis Colon Rectum 29(3):203–210. https://doi.org/10.1007/BF02555027
Kahi CJ, Rex DK (2003) Bowel obstruction and pseudo-obstruction. Gastroenterol Clin N Am 32(4):1229–1247. https://doi.org/10.1016/s0889-8553(03)00091-8
Jain A, Vargas HD (2012) Advances and challenges in the management of acute colonic pseudo-obstruction (Ogilvie syndrome). Clin Colon Rectal Surg 25(1):37–45. https://doi.org/10.1055/s-0032-1301758
Stephenson BM, Morgan AR, Drake N, Salaman JR, Wheeler MH (1993) Parasympathomimetic decompression of acute colonic pseudo-obstruction. Lancet 342(8880):1181–1182. https://doi.org/10.1016/0140-6736(93)92167-r
Durai R (2009) Colonic pseudo-obstruction. Singap Med J 50(3):237–244
Ross SW, Oommen B, Wormer BA et al (2016) Acute colonic pseudo-obstruction: defining the epidemiology, treatment, and adverse outcomes of Ogilvie’s syndrome. Am Surg 82(2):102–111. https://doi.org/10.1177/000313481608200211
De Giorgio R, Knowles CH (2009) Acute colonic pseudo-obstruction. Br J Surg 96(3):229–239. https://doi.org/10.1002/bjs.6480
Saunders MD, Kimmey MB (2005) Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther 22(10):917–925. https://doi.org/10.1111/j.1365-2036.2005.02668.x
Saunders MD (2007) Acute colonic pseudo-obstruction. Gastrointest Endosc Clin N Am 17(2):341–vii. https://doi.org/10.1016/j.giec.2007.03.007
Vogel JD, Feingold DL, Stewart DB et al (2016) Clinical practice guidelines for colon volvulus and acute colonic pseudo-obstruction. Dis Colon Rectum 59(7):589–600. https://doi.org/10.1097/DCR.0000000000000602
Weusten BLAM, Barret M, Bredenoord AJ et al (2020) Endoscopic management of gastrointestinal motility disorders—Part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline [published correction appears in Endoscopy 2020 Jul; 52(7):C7]. Endoscopy 52(7):600–614. https://doi.org/10.1055/a-1171-3174
Naveed M, Jamil LH, Fujii-Lau LL et al (2020) American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus [published correction appears in Gastrointest Endosc 2020 Mar; 91(3):721]. Gastrointest Endosc 91(2):228–235. https://doi.org/10.1016/j.gie.2019.09.007
Alavi K, Poylin V, Davids JS et al (2021) The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colonic volvulus and acute colonic pseudo-obstruction. Dis Colon Rectum 64(9):1046–1057. https://doi.org/10.1097/DCR.0000000000002159
Ramage JI Jr, Baron TH (2003) Percutaneous endoscopic cecostomy: a case series. Gastrointest Endosc 57(6):752–755. https://doi.org/10.1067/mge.2003.197
Lynch CR, Jones RG, Hilden K, Wills JC, Fang JC (2006) Percutaneous endoscopic cecostomy in adults: a case series. Gastrointest Endosc 64(2):279–282. https://doi.org/10.1016/j.gie.2006.02.037
Ponsky JL, Aszodi A, Perse D (1986) Percutaneous endoscopic cecostomy: a new approach to nonobstructive colonic dilation. Gastrointest Endosc 32(2):108–111. https://doi.org/10.1016/s0016-5107(86)71770-7
Agha RA, Sohrabi C, Mathew G et al (2020) The PROCESS 2020 guideline: updating consensus Preferred Reporting Of Case Series in Surgery (PROCESS) guidelines. Int J Surg 84:231–235. https://doi.org/10.1016/j.ijsu.2020.11.005
Vaněk P, Falt P, Urban O (2019) Percutaneous endoscopic cecostomy in the treatment of recurrent colonic pseudo-obstruction: a case report of the first procedure in the Czech Republic. Rozhl Chir 98(9):375–378. https://doi.org/10.33699/PIS.2019.98.9.375-378
Geller A, Petersen BT, Gostout CJ (1996) Endoscopic decompression for acute colonic pseudo-obstruction. Gastrointest Endosc 44(2):144–150. https://doi.org/10.1016/s0016-5107(96)70131-1
Rex DK (1997) Colonoscopy and acute colonic pseudo-obstruction. Gastrointest Endosc Clin N Am 7(3):499–508
ASGE Standards of Practice Committee, Harrison ME, Anderson MA et al (2010) The role of endoscopy in the management of patients with known and suspected colonic obstruction and pseudo-obstruction. Gastrointest Endosc 71(4):669–679. https://doi.org/10.1016/j.gie.2009.11.027
Tun G, Bullas D, Bannaga A, Said EM (2016) Percutaneous endoscopic colostomy: a useful technique when surgery is not an option. Ann Gastroenterol 29(4):477–480. https://doi.org/10.20524/aog.2016.0058
Khayyat YM (2022) Therapeutic utility of percutaneous cecostomy in adults: an updated systematic review. Ther Adv Gastrointest Endosc 15:26317745211073412. https://doi.org/10.1177/26317745211073411. (Published 4 Feb 2022)
National Institute for Health and Care Excellence (2006) Interventional procedure guidance (IPG) percutaneous endoscopic colostomy. NICE. www.nice.org.uk/IPG161. Accessed 26 Oct 2022
Baraza W, Brown S, McAlindon M, Hurlstone P (2007) Prospective analysis of percutaneous endoscopic colostomy at a tertiary referral centre. Br J Surg 94(11):1415–1420. https://doi.org/10.1002/bjs.5858
Cowlam S, Watson C, Elltringham M et al (2007) Percutaneous endoscopic colostomy of the left side of the colon. Gastrointest Endosc 65(7):1007–1014. https://doi.org/10.1016/j.gie.2007.01.012
Salm R, Rückauer K, Waldmann D, Farthmann EH (1988) Endoscopic percutaneous cecostomy (EPC). Surg Endosc 2(2):92–95. https://doi.org/10.1007/BF00704364
Duchalais E, Meurette G, Mantoo SK et al (2015) Percutaneous endoscopic cecostomy for severe constipation in adults: feasibility, durability, functional and quality of life results at 1 year follow-up. Surg Endosc 29(3):620–626. https://doi.org/10.1007/s00464-014-3709-1
Ricard J, Quénéhervé L, Lefevre C et al (2019) Anterograde colonic irrigations by percutaneous endoscopic cecostomy in refractory colorectal functional disorders. Int J Colorectal Dis 34(1):169–175. https://doi.org/10.1007/s00384-018-3183-7
Didailler R, Denost Q, Loughlin P et al (2018) Antegrade enema after total mesorectal excision for rectal cancer: the last chance to avoid definitive colostomy for refractory low anterior resection syndrome and fecal incontinence. Dis Colon Rectum 61(6):667–672. https://doi.org/10.1097/DCR.0000000000001089
Uno Y (2006) Introducer method of percutaneous endoscopic cecostomy and antegrade continence enema by use of the Chait Trapdoor cecostomy catheter in patients with adult neurogenic bowel. Gastrointest Endosc 63(4):666–673. https://doi.org/10.1016/j.gie.2005.12.035
Rawat DJ, Haddad M, Geoghegan N, Clarke S, Fell JM (2004) Percutaneous endoscopic colostomy of the left colon: a new technique for management of intractable constipation in children. Gastrointest Endosc 60(1):39–43. https://doi.org/10.1016/s0016-5107(04)01286-6
Rao AS, Loftus CG, Baron TH (2011) Buried bumper syndrome arising from a percutaneous endoscopic cecostomy tube. Gastrointest Endosc 73(1):168–169. https://doi.org/10.1016/j.gie.2010.04.039
Coron E (2016) Should we recommend PEC and when? Endosc Int Open 4(7):E742–E743. https://doi.org/10.1055/s-0042-105513
Koyfman S, Swartz K, Goldstein AM, Staller K (2017) Laparoscopic-assisted percutaneous endoscopic cecostomy (LAPEC) in children and young adults. J Gastrointest Surg 21(4):676–683. https://doi.org/10.1007/s11605-016-3353-2
Rodriguez L, Flores A, Gilchrist BF, Goldstein AM (2011) Laparoscopic-assisted percutaneous endoscopic cecostomy in children with defecation disorders (with video). Gastrointest Endosc 73(1):98–102. https://doi.org/10.1016/j.gie.2010.09.011
Bertolini D, De Saussure P, Chilcott M, Girardin M, Dumonceau JM (2007) Severe delayed complication after percutaneous endoscopic colostomy for chronic intestinal pseudo-obstruction: a case report and review of the literature. World J Gastroenterol 13(15):2255–2257. https://doi.org/10.3748/wjg.v13.i15.2255
Küllmer A, Schmidt A, Caca K (2016) Percutaneous endoscopic cecostomy (introducer method) in chronic intestinal pseudo-obstruction: report of two cases and literature review. Dig Endosc 28(2):210–215. https://doi.org/10.1111/den.12561
Rivera MT, Kugathasan S, Berger W, Werlin SL (2001) Percutaneous colonoscopic cecostomy for management of chronic constipation in children. Gastrointest Endosc 53(2):225–228. https://doi.org/10.1067/mge.2001.112182
Cascio S, Flett ME, De la Hunt M, Barrett AM, Jaffray B (2004) MACE or cecostomy button for idiopathic constipation in children: a comparison of complications and outcomes. Pediatr Surg Int 20(7):484–487. https://doi.org/10.1007/s00383-004-1220-9
Biyani D, Barrow E, Hodson P, Watson AJ, MacLennan I (2007) Endoscopically placed cecostomy buttons: a trial ACE procedure. Colorectal Dis 9(4):373–376. https://doi.org/10.1111/j.1463-1318.2006.01110.x
Graham CD, Rodriguez L, Flores A, Nurko S, Buchmiller TL (2019) Primary placement of a skin-level cecostomy tube for antegrade colonic enema administration using a modification of the laparoscopic-assisted percutaneous endoscopic cecostomy (LAPEC). J Pediatr Surg 54(3):486–490. https://doi.org/10.1016/j.jpedsurg.2018.09.013
Sgouros SN, Vlachogiannakos J, Vassiliadis K et al (2006) Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut 55(5):638–642. https://doi.org/10.1136/gut.2005.082099
Al-Alawi IK (2010) Percutaneous endoscopic colostomy: a new technique for the treatment of recurrent sigmoid volvulus. Saudi J Gastroenterol 16(2):120–121. https://doi.org/10.4103/1319-3767.61241
Funding
Open access publishing supported by the National Technical Library in Prague. This research received no specific funding from any agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
PV participated in the conceptualization, acquisition, analysis, interpretation of data, and original draft preparation; OU participated in the endoscopist performing procedures and critical revision of manuscript for important intellectual content; PF participated in the conceptualization, endoscopist performing procedures, and critical revision of manuscript for important intellectual content. All authors have reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Disclosures
Petr Vanek, Ondrej Urban, and Premysl Falt declare that they have no conflict of interest to disclose.
Ethical approval
This study was reviewed and approved by the Ethics Committee of the Palacky University and University Hospital Olomouc, approval number 173/21.
Informed consent
Written informed consent was obtained from the patients (for cases 1 and 3) or patients’ next of kin (for case 2) for publication of the details of their medical case and any accompanying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Percutaneous endoscopic cecostomy placement – endoscopic and external viewpoints. Supplementary file1 (MP4 241620 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vanek, P., Urban, O. & Falt, P. Percutaneous endoscopic cecostomy for management of Ogilvie’s syndrome: a case series and literature review with an update on current guidelines (with video). Surg Endosc 37, 8144–8153 (2023). https://doi.org/10.1007/s00464-023-10281-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-023-10281-w